Exablate Neuro / Exablate Prime

by InsightecIL

To provide incisionless tremor treatment via focused ultrasound, expanding indications beyond tremor to other neurological disorders.

DeployStage 4 of 5

FDA approved for tremor. Exablate Prime approved Feb 2026. 30,000+ patients treated at 214 centers.

Updated 5 Feb 2026Checked 11 Oct0 updates this week

Milestones

Next · Expansion to additional neurological indications
  1. Exablate Neuro FDA approval for essential tremor2016Complete.
  2. FDA approval for tremor-dominant Parkinson's disease2018Complete.
  3. 200+ treatment centers active worldwide2025Complete.
  4. Exablate Prime FDA approval2025Complete.
  5. Health Canada approval for Exablate Prime5 Feb 2026Complete.

Most important updates

Upcoming

  1. 2027Expansion to additional neurological indications (next)
  2. 2027Broader reimbursement coverage in Europe and Asia
Primer